pyruvic acid has been researched along with rucaparib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Katayama, K; Noguchi, K; Nonomiya, Y; Sugimoto, Y | 1 |
| Kato, A; Kato, K; Niimi, N; Nishito, Y; Sango, K; Takaku, S; Tatsumi, Y; Yako, H | 1 |
2 other study(ies) available for pyruvic acid and rucaparib
| Article | Year |
|---|---|
Novel pharmacological effects of poly (ADP-ribose) polymerase inhibitor rucaparib on the lactate dehydrogenase pathway.
Topics: Cell Line, Tumor; Female; Humans; Indoles; L-Lactate Dehydrogenase; Lactic Acid; Ovarian Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Pyruvic Acid; Signal Transduction | 2019 |
Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions.
Topics: Adenosine Triphosphate; Animals; Cell Line; Cell Survival; Citric Acid Cycle; Diabetic Nephropathies; Disease Models, Animal; Female; Glucose; Glycolysis; Humans; Hyperglycemia; Indoles; Mice; Neurons; Poly(ADP-ribose) Polymerases; Primary Cell Culture; Pyruvic Acid; Rats; Schwann Cells; Thiamine | 2021 |